These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11064437)

  • 1. Pattern of cytokine secretion by peripheral blood cells of patients with multiple sclerosis in Brazil.
    da Costa P; Yasuda CL; Scagliusi SM; Diaz-Bardales BM; Maciel E; Damasceno BP; Blotta MH; Tilbery CP; Santos LM
    Mult Scler; 2000 Oct; 6(5):293-9. PubMed ID: 11064437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
    Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
    J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
    Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
    J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
    Durán I; Martínez-Cáceres EM; Brieva L; Tintoré M; Montalban X
    Mult Scler; 2001 Jun; 7(3):151-6. PubMed ID: 11475437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients.
    Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
    Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
    Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
    Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
    Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
    Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
    Saresella M; Rolland A; Marventano I; Cavarretta R; Caputo D; Marche P; Perron H; Clerici M
    Mult Scler; 2009 Apr; 15(4):443-7. PubMed ID: 19251836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.
    Zang YC; Yang D; Hong J; Tejada-Simon MV; Rivera VM; Zhang JZ
    Neurology; 2000 Aug; 55(3):397-404. PubMed ID: 10932275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis.
    Trabattoni D; Ferrante P; Fusi ML; Saresella M; Caputo D; Urnovitz H; Cazzullo CL; Clerici M
    J Neurovirol; 2000 May; 6 Suppl 2():S38-41. PubMed ID: 10871783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
    Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
    J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.